SUBSCRIBE
SUBSCRIBE
News   Business

Enzon Pharmaceuticals, Inc. Shareholder Opposes Biotech Business Spin-off

November 26, 2008 | 
1 min read

Nov 26 (Reuters) - Enzon Pharmaceuticals Inc’s shareholder DellaCamera Capital said it was opposed to the spin-off of the company’s biotechnology business.

Startups
MORE ON THIS TOPIC
Business
A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
January 16, 2025
 · 
1 min read
 · 
Lori Ellis
San Francisco, USA - May 20, 2022: historic Cable Car Powell Hyde Line on turntable at Powell Street terminal at Market Street in downtown San Francisco, California CA, USA.
Pipeline
JPM25 Day 3: AbbVie, Gilead, GSK and Dyne
January 16, 2025
 · 
3 min read
 · 
Tristan Manalac
Business
Dispatches From JPM, Biogen’s Sage Buyout Offer, Pfizer’s Obesity Play, More
January 15, 2025
 · 
1 min read
 · 
Heather McKenzie
Psychedelic Brain
People
Lykos Loses Five Board Directors After FDA Rejection
January 15, 2025
 · 
2 min read
 · 
Tristan Manalac